The Silent Crossroad: Systemic Pharmacotherapy and Its Implications on Oral Health
Keywords:
Oral cavity, Editorial Note, Hypofunction, Pharmacotherapy, XerostomiaAbstract
The human oral cavity serves as an exceptionally sensitive barometer of the general physical well-being of any individual. Historically, medicine and dentistry operated within distinct professional categories; however, modern clinical science increasingly demands a unified interdisciplinary paradigm. As pharmacotherapy continues to evolve with remarkable precision and sophistication, the systemic administration of therapeutics frequently exerts secondary, adverse effects on the oral tissues. From medication-induced hyposalivation to the complex soft-tissue mucosal reactions and alveolar bone homeostasis disruptions, systemic drug therapies profoundly influence oral physiology. For pharmaceutical scientists, pharmacologists, and dental professionals, understanding the multifaceted relationship between drugs and oral health is no longer merely an academic exercise it is an indispensable clinical imperative.
References
1. Leo, M., D'Angeli, F., Genovese, C., Spila, A., Miele, C., Ramadan, D., Ferroni, P., & Guadagni, F. (2024). Oral Health and Nutraceutical Agents. International journal of molecular sciences, 25(17), 9733. https://doi.org/10.3390/ijms25179733
2. Deng, L., Guan, G., Cannon, R. D., & Mei, L. (2025). Age-related oral microbiota dysbiosis and systemic diseases. Microbial pathogenesis, 205, 107717. https://doi.org/10.1016/j.micpath.2025.107717
3. Visvanathan, V., & Nix, P. (2010). Managing the patient presenting with xerostomia: a review. International journal of clinical practice, 64(3), 404-407. https://doi.org/10.1111/j.1742-1241.2009.02132.x
4. Furness, S., Worthington, H. V., Bryan, G., Birchenough, S., & McMillan, R. (2011). Interventions for the management of dry mouth: topical therapies. The Cochrane database of systematic reviews, 2011(12), CD008934. https://doi.org/10.1002/14651858.CD008934.pub2
5. Carrozzo, M., Porter, S., Mercadante, V., & Fedele, S. (2019). Oral lichen planus: A disease or a spectrum of tissue reactions? Types, causes, diagnostic algorhythms, prognosis, management strategies. Periodontology 2000, 80(1), 105–125. https://doi.org/10.1111/prd.12260
6. Scully, C., & Bagan, J. V. (2004). Adverse drug reactions in the orofacial region. Critical reviews in oral biology and medicine: an official publication of the American Association of Oral Biologists, 15(4), 221–239. https://doi.org/10.1177/154411130401500405
7. Al-Hashimi, I., Schifter, M., Lockhart, P. B., Wray, D., Brennan, M., Migliorati, C. A., Axéll, T., Bruce, A. J., Carpenter, W., Eisenberg, E., Epstein, J. B., Holmstrup, P., Jontell, M., Lozada-Nur, F., Nair, R., Silverman, B., Thongprasom, K., Thornhill, M., Warnakulasuriya, S., & van der Waal, I. (2007). Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 103 Suppl, S25.e1–S25.e12. https://doi.org/10.1016/j.tripleo.2006.11.001
8. Stone, R., Fliedner, M. C., & Smiet, A. C. (2005). Management of oral mucositis in patients with cancer. European journal of oncology nursing: the official journal of European Oncology Nursing Society, 9 Suppl 1, S24–S32. https://doi.org/10.1016/j.ejon.2005.08.004.
9. Auquier-Dunant, A., Mockenhaupt, M., Naldi, L., Correia, O., Schröder, W., Roujeau, J. C., & SCAR Study Group. Severe Cutaneous Adverse Reactions (2002). Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Archives of dermatology, 138(8), 1019–1024. https://doi.org/10.1001/archderm.138.8.1019.
10. Zhang, R., Wu, J., Zhu, J., Wang, X., & Song, J. (2022). Bibliometric analysis of research trends and characteristics of drug-induced gingival overgrowth. Frontiers in public health, 10, 979861. https://doi.org/10.3389/fpubh.2022.979861
11. Nanda, T., Singh, B., Sharma, P., & Arora, K. S. (2019). Cyclosporine A and amlodipine induced gingival overgrowth in a kidney transplant recipient: case presentation with literature review. BMJ Case Reports, 12(5), e229587. https://doi.org/10.1136/bcr-2019-229587
12. AlDhalaan, N. A., BaQais, A., & Al-Omar, A. (2020). Medication-related Osteonecrosis of the Jaw: A Review. Cureus, 12(2), e6944. https://doi.org/10.7759/cureus.6944
13. Cho, J., Feldman, G., Tomlinson, R., Taub, D., & Diecidue, R. (2024). Medication-related osteonecrosis of the jaw (MRONJ) systemic review: mevalonate pathway mechanisms explored. Oral surgery, oral medicine, oral pathology and oral radiology, 138(4), 475–483. https://doi.org/10.1016/j.oooo.2024.05.014
14. Frutuoso, F., Freitas, F., Vilares, M., Francisco, H., Marques, D., Caramês, J., & Moreira, A. (2024). Medication-Related Osteonecrosis of the Jaw: A Systematic Review of Case Reports and Case Series. Diseases (Basel, Switzerland), 12(9), 205. https://doi.org/10.3390/diseases12090205
15. Kuroshima, S., Sasaki, M., & Sawase, T. (2019). Medication-related osteonecrosis of the jaw: A literature review. Journal of oral biosciences, 61(2), 99–104. https://doi.org/10.1016/j.job.2019.03.005
16. Zhang, R., Wu, J., Zhu, J., Wang, X., & Song, J. (2022). Bibliometric analysis of research trends and characteristics of drug-induced gingival overgrowth. Frontiers in Public Health, 10, 979861. https://doi.org/10.3389/fpubh.2022.979861
Downloads
Published
Issue
Section
License
Copyright (c) 2026 S. Mitthra (Author)
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
